About the Juvenile Xanthogranuloma Session
Juvenile Xanthogranuloma (JXG) is a benign condition primarily seen in infants and young children, occasionally affecting the eye in ophthalmology. It presents as a solitary yellow-orange nodule on the eyelid, conjunctiva, or iris, arising from histiocytes. Symptoms may include eyelid swelling, ptosis, or, in severe cases, vision impairment if the iris is involved.
Diagnosis relies on clinical examination and sometimes biopsy. Most cases resolve without intervention, but surgical removal may be necessary for cosmetic reasons or if the lesion affects vision or eyelid function. Regular monitoring by an ophthalmologist is crucial to detect any recurrence or complications. While rare, prompt evaluation ensures proper management and favorable outcomes for patients with Juvenile Xanthogranuloma affecting the eye.
Topics Covered in Juvenile Xanthogranuloma
Iris Xanthogranuloma
Spontaneous Hyphema
Secondary Glaucoma
Eyelid & Conjunctival Nodules
Touton Giant Cells
Non-Langerhans Histiocytosis
Related Scientific Sessions at IOC 2027
Why Attend the Juvenile Xanthogranuloma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Present Your Research
Oral and poster slots for original Juvenile Xanthogranuloma work, reviewed by the scientific committee.
Network Globally
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Publish & Get Indexed
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Learn from Keynotes
Plenary lectures from leading voices shaping Juvenile Xanthogranuloma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IOC 2027 for the Juvenile Xanthogranuloma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Juvenile Xanthogranuloma Conference 2027 — FAQs
What is the Juvenile Xanthogranuloma track at IOC 2027?
The Juvenile Xanthogranuloma track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Juvenile Xanthogranuloma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Juvenile Xanthogranuloma sessions?
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Juvenile Xanthogranuloma are all welcome — whether presenting or attending.
Can I present my research in the Juvenile Xanthogranuloma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Juvenile Xanthogranuloma sessions?
Yes. IOC 2027 is a hybrid conference — attend the Juvenile Xanthogranuloma track in person in Singapore or join live online, with on-demand access afterward.
Join the IOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.